PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 13168213

Radioactive gold in prostatic cancer.

R O BEADLES·J M LEWIS
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Gold RadioisotopesHumansMaleProstatic NeoplasmsGOLD/radioactivePROSTATE/neoplasmsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R O BEADLES, J M LEWIS. 1954. Radioactive gold in prostatic cancer.. https://pubmed.ncbi.nlm.nih.gov/13168213/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Radiopharmaceuticals in sentinel lymph-node detection - an overview.

Biopsy of the first tumour-draining lymph node (sentinel node, SN) is bound to become the procedure of choice in regional staging of melanoma and breast cancer patients. Several radiopharmaceuticals have been developed for lymphoscintigraphy. In this paper we review the most frequently used radiopharmaceuticals for their appropriateness in the sentinel-node procedure. We conclude that accurate localization of SNs is demonstrated using technetium-99m-sulfur colloid (99mTc-SC), 99mTc antimony trisulfide colloid (99mTc-ATC) [10] and 99mTc nanocolloidal albumin (99mTc-CA). 99mTc-Ca and 99mTc-SC are both available in Europe. In the United States 99mTc-SC is the only registered tracer for lymphoscintigraphy.

Gold Radioisotopes↗